LataMed AI Corp. (OTC: LMED), a healthcare technology company developing digital health and artificial intelligence solutions for Latin America, announced its participation in the Artificial Intelligence & Health Markets 2026 conference, scheduled for August 13 and 14, 2026, at Universidad Santa Maria in Caracas, Venezuela. The event will bring together students, faculty, and participants from systems engineering and healthcare-related academic programs, including pharmacy, dentistry, and laboratory sciences, to explore practical applications of AI and automation.
Representing LataMed AI will be Dr. Kevin Rodan Levy, Chief Executive Officer, and Carlos Pena, Chief Financial Officer. Their presentation will address the evolving role of artificial intelligence in healthcare, systems engineering, digital infrastructure, and professional decision-making. The company intends to discuss how AI-supported tools can assist healthcare professionals with medical-data evaluation, clinical workflows, and operational decision-making, as well as how automation may support the organization, reliability, and efficiency of technology systems in healthcare and other complex environments.
A key emphasis will be on maintaining qualified professional oversight when implementing AI. LataMed AI’s technologies are designed to enhance human capabilities and support informed decision-making, rather than replace the independent judgment of healthcare professionals, engineers, laboratory personnel, or other qualified individuals. Additional conference topics will include the integration of AI and automation into existing systems, responsible data use, privacy and information security, operational risk management, and practical considerations for developing and deploying technology in healthcare settings.
The company will also discuss the continued development of its healthcare technology ecosystem, particularly the roles of CardioAI, PulmoAI, and NeuroAI. These AI-supported platforms are being developed to assist healthcare professionals in evaluating and managing cardiovascular, pulmonary, and neurological health information, subject to ongoing development, testing, regulatory requirements, and commercial implementation.
“Artificial Intelligence & Health Markets 2026 provides an important opportunity to engage directly with students, educators, and future professionals who will help shape the responsible use of artificial intelligence in healthcare and systems engineering,” said Dr. Kevin Rodan Levy. “Our objective is to share practical perspectives on how intelligent technologies can support professional decision-making, improve digital workflows, and contribute to the continued development of healthcare infrastructure in Latin America.”
Management believes that engagement with universities can increase awareness of emerging healthcare technologies, encourage responsible discussion about AI, and strengthen relationships with future professionals. Participation also offers the company a chance to understand the perspectives of students, educators, researchers, and technical professionals as it develops digital health and AI-supported solutions for the Latin American market.
LataMed AI’s participation aligns with its broader strategy of supporting education, professional collaboration, and the responsible adoption of digital healthcare infrastructure throughout the region. The company intends to continue evaluating opportunities to participate in academic, healthcare, and technology forums that align with its business and educational objectives.
It is important to note that participation in the conference does not constitute an endorsement of LataMed AI or its technologies by Universidad Santa Maria, and the event does not guarantee future research collaborations, employment arrangements, commercial relationships, technology adoption, regulatory authorization, revenue, or other financial benefits.
For more information about LataMed AI and its initiatives, interested parties can visit https://latamed.ai or review the company’s filings with the U.S. Securities and Exchange Commission at www.sec.gov.
